<DOC>
	<DOCNO>NCT02823600</DOCNO>
	<brief_summary>The purpose research study look retinal abnormality outpatient renal dialysis patient use FDA approve RetinaVue 100 hand-held ( non-mydriatic ) camera .</brief_summary>
	<brief_title>Feasibility Study Retinal Screening Using RetinaVue 100 Camera Outpatient Dialysis Centers</brief_title>
	<detailed_description>There study evaluate ( diabetic non-diabetic ) retinopathy renal dialysis patient population ( ~300,000 Americans ) . Approximately 50 % population End-stage Retinal Disease ( ESRD ) due diabetes . Dialysis patient among debilitated patient , thus , even barrier receive recommend annual retinal evaluation . The advent RetiaVue hand-held retinal camera hold great promise population , dialysis patient access medical care 3 time week , several hour time dialysis clinic .</detailed_description>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>The subject must currently seek treatment endstage renal disease ( ESRD ) one specify dialysis clinic . The subject must â‰¥ 18 year age . The subject &lt; 18 year age . No exclusion make basis gender , ethnicity , race .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>retinal screening</keyword>
	<keyword>outpatient dialysis</keyword>
</DOC>